Cellular Senescence in Diabetic Wounds

When Too Many Retirees Stress the System

Marjana Tomic-Canic, Luisa A. DiPietro

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

Aging and cellular senescence are known contributors to the pathophysiology of diabetic nonhealing wounds. However, the dynamic interplay of senescent cells in diabetic wounds is not well understood. Wilkinson et al. show that macrophages, which constitute a large portion of accumulated senescent cells, release a senescence-associated secretory profile (SASP) that is rich in CXCR2 ligands, which drive fibroblasts toward a profibrotic and senescent phenotype. A selective CXCR2 antagonist promoted healing of diabetic wounds, showing a new avenue for potential therapeutic developments.

Original languageEnglish (US)
Pages (from-to)997-999
Number of pages3
JournalJournal of Investigative Dermatology
Volume139
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Macrophages
Cell Aging
Fibroblasts
Aging of materials
Ligands
Wounds and Injuries
Wound Healing
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Cellular Senescence in Diabetic Wounds : When Too Many Retirees Stress the System. / Tomic-Canic, Marjana; DiPietro, Luisa A.

In: Journal of Investigative Dermatology, Vol. 139, No. 5, 01.05.2019, p. 997-999.

Research output: Contribution to journalComment/debate

@article{de1f8b3d209e4acc864fca9ab3eb7742,
title = "Cellular Senescence in Diabetic Wounds: When Too Many Retirees Stress the System",
abstract = "Aging and cellular senescence are known contributors to the pathophysiology of diabetic nonhealing wounds. However, the dynamic interplay of senescent cells in diabetic wounds is not well understood. Wilkinson et al. show that macrophages, which constitute a large portion of accumulated senescent cells, release a senescence-associated secretory profile (SASP) that is rich in CXCR2 ligands, which drive fibroblasts toward a profibrotic and senescent phenotype. A selective CXCR2 antagonist promoted healing of diabetic wounds, showing a new avenue for potential therapeutic developments.",
author = "Marjana Tomic-Canic and DiPietro, {Luisa A.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.jid.2019.02.019",
language = "English (US)",
volume = "139",
pages = "997--999",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Cellular Senescence in Diabetic Wounds

T2 - When Too Many Retirees Stress the System

AU - Tomic-Canic, Marjana

AU - DiPietro, Luisa A.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Aging and cellular senescence are known contributors to the pathophysiology of diabetic nonhealing wounds. However, the dynamic interplay of senescent cells in diabetic wounds is not well understood. Wilkinson et al. show that macrophages, which constitute a large portion of accumulated senescent cells, release a senescence-associated secretory profile (SASP) that is rich in CXCR2 ligands, which drive fibroblasts toward a profibrotic and senescent phenotype. A selective CXCR2 antagonist promoted healing of diabetic wounds, showing a new avenue for potential therapeutic developments.

AB - Aging and cellular senescence are known contributors to the pathophysiology of diabetic nonhealing wounds. However, the dynamic interplay of senescent cells in diabetic wounds is not well understood. Wilkinson et al. show that macrophages, which constitute a large portion of accumulated senescent cells, release a senescence-associated secretory profile (SASP) that is rich in CXCR2 ligands, which drive fibroblasts toward a profibrotic and senescent phenotype. A selective CXCR2 antagonist promoted healing of diabetic wounds, showing a new avenue for potential therapeutic developments.

UR - http://www.scopus.com/inward/record.url?scp=85064170570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064170570&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2019.02.019

DO - 10.1016/j.jid.2019.02.019

M3 - Comment/debate

VL - 139

SP - 997

EP - 999

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -